In patients with chronic obstructive pulmonary disease (COPD), new initiation of beta2-agonist therapy, such as short-acting beta2-agonists (SABA), long-acting beta2-agonists (LABA), or inhaled ...
I really didn't see the death of short-acting beta-agonists (SABAs) coming. Sure, I'd read the SYGMA trials, [1,2] and yes, I was aware of lobbying from the "other side of the pond" (Europe). [3] So I ...
Credit: Getty Images. Is asthma triple therapy with umeclidinium plus fluticasone furoate/vilanterol effective for patients with uncontrolled asthma who overuse SABA as rescue therapy? In patients ...
Chronic obstructive pulmonary disease (COPD) patients should be monitored for the onset of arrhythmia when they begin bronchodilator therapy, say the authors of a Canadian study. The research shows ...
Studies suggest that differences in asthma medication use may contribute to asthma morbidity in ethnic minority populations, 16,17 yet these groups are often under-represented in asthma research. To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results